Dose Escalating Study of BPI-3016 in Healthy Subjects

Clinical trial NCT03188848 · UNKNOWN

Trial details

NCT number: NCT03188848
Sponsor: Betta Pharmaceuticals Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subject

Start date: 2017-05-24
Primary completion: 2019-07-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.